Samjo Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-185,000
Closed -$2.25M 19
2022
Q1
$2.25M Buy
+185,000
New +$3.89M 1.92% 13
2021
Q1
Sell
-70,000
Closed -$3.77M 21
2020
Q4
$3.77M Buy
+70,000
New +$3.16M 3.21% 10

Other funds holding NEO

Samjo Capital's NEO Position: Q2 2022 in Review

Samjo Capital sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 185,000 shares — an estimated $2.25M sold.

Samjo Capital first reported a position in NEO in Q4 2020 and held it in 2 quarters. The position peaked at $3.77M in Q4 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Samjo Capital reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Samjo Capital sold 185,000 NeoGenomics shares in Q2 2022, an estimated $2.25M.
  • Samjo Capital first reported a position in NeoGenomics in Q4 2020 and held it in 2 quarters.
  • Samjo Capital's NeoGenomics position peaked at $3.77M in Q4 2020.
  • 239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Samjo Capital's 13F filing for Q2 2022, filed 4 Aug 2022.